Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MORC family CW-type zinc finger protein 3 (MORC3) is a nuclear matrix protein containing a GHKL-type ATPase domain, a CW-type zinc finger domain, and coiled-coil regions. It acts as a chromatin-associated protein that recognizes and binds methylated histone H3 lysine 4 (H3K4me3) through its CW domain, regulating chromatin accessibility, transcription, and participation in DNA damage response. Through ATP-dependent dimerization, MORC3 forms nuclear bodies and localizes to specific genomic loci. It also displays RNA binding and innate antiviral activity, and mutations, or autoantibodies targeting MORC3 are associated with certain cancers, autoimmune conditions (notably dermatomyositis), and developmental disorders. Key functional aspects include its autoinhibition by CW-ATPase domain interaction, activation by histone tail binding, and modulation of catalytic activity essential for chromatin organization.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MORC family CW-type zinc finger protein 3 (MORC3).